77 related articles for article (PubMed ID: 21114487)
1. Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells.
Hsu CP; Chen YL; Huang CC; Chou CC; Liu CL; Hung CH; Kao TY; Chung YC
Eur J Clin Invest; 2011 Mar; 41(3):277-84. PubMed ID: 21114487
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
3. Influence of interleukin-6 on the invasiveness of human colorectal carcinoma.
Hsu CP; Chung YC
Anticancer Res; 2006; 26(6B):4607-14. PubMed ID: 17201185
[TBL] [Abstract][Full Text] [Related]
4. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.
Wang LS; Chow KC; Wu CW
Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408
[TBL] [Abstract][Full Text] [Related]
5. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
[TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U
Cancer Res; 2001 Mar; 61(5):2200-6. PubMed ID: 11280787
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts.
Salcedo R; Martins-Green M; Gertz B; Oppenheim JJ; Murphy WJ
Clin Cancer Res; 2002 Aug; 8(8):2655-65. PubMed ID: 12171898
[TBL] [Abstract][Full Text] [Related]
8. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
Itoh Y; Joh T; Tanida S; Sasaki M; Kataoka H; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Kubota H; Mori Y; Ohara H; Nomura T; Higashiyama S; Itoh M
Cytokine; 2005 Mar; 29(6):275-82. PubMed ID: 15749028
[TBL] [Abstract][Full Text] [Related]
9. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma.
Labbozzetta M; Notarbartolo M; Poma P; Giannitrapani L; Cervello M; Montalto G; D'Alessandro N
Ann N Y Acad Sci; 2006 Nov; 1089():268-75. PubMed ID: 17261774
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: relevance for tumour progression.
Brozek W; Bises G; Girsch T; Cross HS; Kaiser HE; Peterlik M
Eur J Cancer; 2005 Oct; 41(15):2347-54. PubMed ID: 16176872
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells.
Yoshizaki A; Nakayama T; Yamazumi K; Yakata Y; Taba M; Sekine I
Int J Oncol; 2006 Oct; 29(4):869-76. PubMed ID: 16964382
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S
Am J Pathol; 2007 Jun; 170(6):2149-58. PubMed ID: 17525280
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro.
Iglesias M; Plowman GD; Woodworth CD
Am J Pathol; 1995 Apr; 146(4):944-52. PubMed ID: 7717461
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract][Full Text] [Related]
16. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
Gaillard JP; Liautard J; Klein B; Brochier J
Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
Rose-John S; Scheller J; Elson G; Jones SA
J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
